Minerva Neurosciences, Inc. Current Assets
Minerva Neurosciences, Inc. (NERV) had Current Assets of $79.73 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $79.73M.
- 2026-03-31: Assets, Current $79.11M.
- 2025-12-31: Assets, Current $83.10M.
- 2025-09-30: Assets, Current $13.02M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $79.73M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $79.11M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $83.10M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $13.02M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $15.55M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $17.92M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $22.27M 10-K · filed 2026-03-11 |
| 2024-09-30 | $27.94M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $31.41M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $35.62M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $42.00M 10-K · filed 2025-02-25 |
| 2023-09-30 | $48.23M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $52.23M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $36.67M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $40.16M 10-K · filed 2024-02-22 |
| 2022-09-30 | $44.84M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $50.04M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $55.70M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $62.20M 10-K · filed 2023-03-08 |
| 2021-09-30 | $67.44M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $75.23M 10-Q · filed 2021-08-02 |
| 2021-03-31 | $81.69M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $27.44M 10-K · filed 2022-03-01 |
| 2020-09-30 | $34.99M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $35.89M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $38.47M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $47.14M 10-K · filed 2021-03-08 |
| 2019-09-30 | $61.41M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $70.85M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $80.32M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $90.02M 10-K · filed 2020-03-09 |
| 2018-09-30 | $101.40M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $111.82M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $125.34M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $129.54M 10-K · filed 2019-03-12 |
| 2017-09-30 | $134.08M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $78.07M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $86.23M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $83.86M 10-K · filed 2018-03-12 |
| 2016-09-30 | $92.64M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $97.42M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $45.34M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $33.48M 10-K · filed 2017-03-13 |
| 2015-09-30 | $38.81M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $35.78M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $52.74M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $19.34M 10-K · filed 2016-03-14 |
| 2014-09-30 | $24.22M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $513.22K 10-Q · filed 2014-08-07 |
| 2013-12-31 | $1.82M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |